東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/04/22 | 2,535 | 2,562 | 2,528 | 2,562 | +38 | +1.5% | 51,600 |
2025/04/21 | 2,531 | 2,541 | 2,508 | 2,524 | -24 | -0.9% | 42,300 |
2025/04/18 | 2,514 | 2,548 | 2,509 | 2,548 | +63 | +2.5% | 64,100 |
2025/04/17 | 2,492 | 2,494 | 2,468 | 2,485 | -8 | -0.3% | 48,700 |
2025/04/16 | 2,470 | 2,493 | 2,446 | 2,493 | +22 | +0.9% | 87,100 |
2025/04/15 | 2,483 | 2,498 | 2,470 | 2,471 | +32 | +1.3% | 144,800 |
2025/04/14 | 2,430 | 2,469 | 2,422 | 2,439 | +27 | +1.1% | 76,200 |
2025/04/11 | 2,426 | 2,430 | 2,379 | 2,412 | -78 | -3.1% | 105,800 |
2025/04/10 | 2,525 | 2,525 | 2,463 | 2,490 | +123 | +5.2% | 103,200 |
2025/04/09 | 2,408 | 2,417 | 2,355 | 2,367 | -91 | -3.7% | 120,900 |
2025/04/08 | 2,436 | 2,458 | 2,404 | 2,458 | +89 | +3.8% | 179,000 |
2025/04/07 | 2,330 | 2,414 | 2,298 | 2,369 | -161 | -6.4% | 267,300 |
2025/04/04 | 2,542 | 2,573 | 2,496 | 2,530 | -57 | -2.2% | 170,300 |
2025/04/03 | 2,550 | 2,602 | 2,532 | 2,587 | -43 | -1.6% | 167,600 |
2025/04/02 | 2,701 | 2,709 | 2,630 | 2,630 | -70 | -2.6% | 99,000 |
2025/04/01 | 2,692 | 2,715 | 2,688 | 2,700 | +21 | +0.8% | 84,300 |
2025/03/31 | 2,720 | 2,729 | 2,674 | 2,679 | -64 | -2.3% | 198,600 |
2025/03/28 | 2,771 | 2,779 | 2,743 | 2,743 | -55 | -2% | 82,800 |
2025/03/27 | 2,775 | 2,798 | 2,765 | 2,798 | -4 | -0.1% | 84,700 |
2025/03/26 | 2,802 | 2,815 | 2,791 | 2,802 | +2 | +0.1% | 86,600 |
2025/03/25 | 2,790 | 2,812 | 2,771 | 2,800 | +10 | +0.4% | 71,700 |
2025/03/24 | 2,820 | 2,820 | 2,750 | 2,790 | -12 | -0.4% | 154,900 |
2025/03/21 | 2,780 | 2,816 | 2,780 | 2,802 | +24 | +0.9% | 106,000 |
2025/03/19 | 2,770 | 2,790 | 2,767 | 2,778 | +8 | +0.3% | 64,700 |
2025/03/18 | 2,765 | 2,776 | 2,755 | 2,770 | +10 | +0.4% | 121,100 |
2025/03/17 | 2,762 | 2,783 | 2,756 | 2,760 | -2 | -0.1% | 75,200 |
2025/03/14 | 2,730 | 2,780 | 2,725 | 2,762 | +11 | +0.4% | 115,300 |
2025/03/13 | 2,791 | 2,791 | 2,735 | 2,751 | -58 | -2.1% | 151,900 |
2025/03/12 | 2,692 | 2,819 | 2,688 | 2,809 | +97 | +3.6% | 249,800 |
2025/03/11 | 2,740 | 2,757 | 2,672 | 2,712 | -70 | -2.5% | 197,800 |
2025/03/10 | 2,821 | 2,828 | 2,773 | 2,782 | -39 | -1.4% | 150,200 |
2025/03/07 | 2,857 | 3,050 | 2,781 | 2,821 | -71 | -2.5% | 547,200 |
2025/03/06 | 2,929 | 2,953 | 2,876 | 2,892 | -30 | -1% | 102,500 |
2025/03/05 | 2,881 | 2,938 | 2,860 | 2,922 | +41 | +1.4% | 147,600 |
2025/03/04 | 2,924 | 2,999 | 2,874 | 2,881 | +57 | +2% | 276,600 |
2025/03/03 | 2,837 | 2,855 | 2,822 | 2,824 | +34 | +1.2% | 98,900 |
2025/02/28 | 2,848 | 2,862 | 2,777 | 2,790 | -50 | -1.8% | 150,300 |
2025/02/27 | 2,860 | 2,864 | 2,839 | 2,840 | -8 | -0.3% | 49,500 |
2025/02/26 | 2,835 | 2,853 | 2,813 | 2,848 | +9 | +0.3% | 103,300 |
2025/02/25 | 2,811 | 2,853 | 2,804 | 2,839 | +13 | +0.5% | 103,300 |
2025/02/21 | 2,838 | 2,856 | 2,804 | 2,826 | -29 | -1% | 142,600 |
2025/02/20 | 2,903 | 2,903 | 2,835 | 2,855 | -65 | -2.2% | 109,800 |
2025/02/19 | 2,968 | 3,010 | 2,920 | 2,920 | -74 | -2.5% | 99,900 |
2025/02/18 | 2,998 | 3,020 | 2,957 | 2,994 | -26 | -0.9% | 93,700 |
2025/02/17 | 3,035 | 3,075 | 3,010 | 3,020 | ±0 | ±0% | 84,500 |
2025/02/14 | 3,100 | 3,115 | 2,951 | 3,020 | -10 | -0.3% | 258,500 |
2025/02/13 | 3,010 | 3,050 | 3,005 | 3,030 | +71 | +2.4% | 132,500 |
2025/02/12 | 2,947 | 2,991 | 2,930 | 2,959 | +40 | +1.4% | 164,600 |
2025/02/10 | 2,916 | 2,932 | 2,902 | 2,919 | +10 | +0.3% | 84,000 |
2025/02/07 | 2,902 | 2,924 | 2,883 | 2,909 | -10 | -0.3% | 61,900 |
51~
100
件表示中 / 6988件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 293,400円 | +7.9% | -3.3% | 2.73% | 8.16倍 | 0.84倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 311,500円 | +21.7% | +999.9% | 0.00% | 13.05倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
サンバイオ | 217,100円 | - | - | 0.00% | - | 100.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ゼリア新薬 | 204,200円 | +3.1% | -6.5% | 2.35% | 9.47倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 290,100円 | +5.1% | -7.0% | 2.76% | 19.04倍 | 0.79倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム